Specifically, experimental studies confirm that 4-NP acts as an agonist of estrogen receptor α (ERα) in MCF-7 human breast cancer cells, thereby promoting estrogenic signaling pathways implicated in breast carcinogenesis [18]. This evidence concerns the gene ESR1 and breast cancer.